- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/29 - Hepatitis virus
Patent holdings for IPC class A61K 39/29
Total number of patents in this class: 1071
10-year publication summary
|
88
|
60
|
78
|
86
|
61
|
67
|
56
|
51
|
46
|
34
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Governors of the University of Alberta | 878 |
31 |
| The Trustees of the University of Pennsylvania | 4441 |
30 |
| Janssen Sciences Ireland Unlimited Company | 373 |
26 |
| Glaxosmithkline Biologicals S.A. | 1603 |
25 |
| Xiamen University | 587 |
17 |
| The Johns Hopkins University | 5948 |
14 |
| Hvidovre Hospital | 64 |
13 |
| GlobeImmune, Inc. | 72 |
12 |
| Transgene S.A. | 116 |
11 |
| The Regents of the University of California | 20924 |
10 |
| Gilead Sciences, Inc. | 2249 |
10 |
| The Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 58 |
10 |
| Oxford University Innovation Limited | 1686 |
10 |
| Tokyo Metropolitan Institute of Medical Science | 116 |
10 |
| The Wistar Institute of Anatomy and Biology | 489 |
10 |
| Toko Yakuhin Kogyo Co., Ltd. | 32 |
10 |
| The Regents of the University of Michigan | 5051 |
9 |
| Japan as Represented by Director-General of National Institute of Infectious Diseases | 68 |
9 |
| University of Washington | 2472 |
9 |
| Xiamen Innovax Biotech Co., Ltd. | 114 |
9 |
| Other owners | 786 |